This report examines the relation of upper and lower extremity motor performance to functional impairment among 371 persons with probable Alzheimer’s disease (AD). Cognitive and motor performance tests were administered at 6-month intervals for up to 4 years. Motor performance was assessed using 3 lower extremity tests and 2 upper extremity tests. Functional impairment was measured at 3-month intervals using caregiver ratings of impairments in activities of daily living, mobility, and range of motion. Both lower and upper extremity performance were inversely related to functional impairments on all 3 scales (all Ps < .001), after controlling for age, sex, and level of cognitive impairment. This suggests that motor performance contributes to functional impairments in AD, independent of cognitive impairment. It is important to preserve motor performance in individuals with AD because it influences physical function throughout the course of the disease.
Aguero-Torres H., Fratiglioni L., Guo Z., Viitanen M., von Strauss E., Winblad B.Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study . Am J Public Health. 1998;88(10):1452-1456.
2.
Thomas VSExcess functional disability among demented subjects? Findings from the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord. 2001;12(3):206-210.
3.
Sauvaget C., Yamada M., Fujiwara S., Sasaki H., Mimori Y.Dementia as a predictor of functional disability: a four-year follow-up study . Gerontology. 2002;48(4):226-233.
4.
Zanetti O., Bianchetti A., Frisoni GBDeterminates of disability in Alzheimer’s disease. Int J Geriatr Psychiatry. 1993;8(7):581-586.
5.
Hill RD, Backman L., Fratiglioni L.Determinants of functional abilities in dementia. J Am Geriatr Soc. 1995;43(10):1092-1097.
6.
Suh GH, Ju YS, Yeon BK, Shah A.A longitudinal study of Alzheimer’s disease: rates of cognitive and functional decline. Int J Geriatr Psychiatry. 2004;19(9):817-824.
7.
Feldman HH, Van Baelen B., Kavanagh SM, Torfs KECognition, function, and caregiving time patterns in patients with mild-to-moderate Alzheimer disease: a 12-month analysis. Alzheimer Dis Assoc Disord. 2005;19(1):29-36.
8.
Sarazin M., Stern Y., Berr C., Riba A., Albert M., Brandt J., et al. Neuropsychological predictors of dependency in patients with Alzheimer disease. Neurology. 2005;64(6):1027-1031.
9.
Liu KP, Chan CC, Chu MM, Ng TY, Chu LW, Hui FS, et al. Activities of daily living performance in dementia. Acta Neurol Scand. 2007;116(2):91-95.
10.
Louis ED, Tang MX, Schupf N., Mayeux R.Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol. 2005 ;62(2):297-302.
11.
Fleischman DA, Wilson RS, Schneider JA, Bienias JL, Bennett DAParkinsonian signs and functional disability in old age. Exp Aging Res. 2007;33(1):59-76.
12.
Lopez OL, Wisnieski SR, Becker JT, Boller F., DeKosky STExtrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol. 1997;54(8):969-975.
13.
Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DAProgression of parkinsonian signs in Alzheimer’s disease. Neurology. 2000;54(6):1284-1289.
14.
Bennett DA, Shannon KM, Beckett LA, Wilson RSDimensionality of parkinsonian signs in aging and Alzheimer’s disease . J Gerontol A Biol Sci Med Sci. 1999;54(4):M191-M196.
15.
Tsolaki M., Kokarida K., Iakovidou V., Stilopoulos E., Meimaris J., Kazis A.Extrapyramidal symptoms and signs in Alzheimer’s disease: prevalence and correlation with the first symptom. Am J Alzheimers Dis Other Demen. 2001;16(5):268-278.
16.
Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DWThe pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs. Neurology. 2005;64(8):1397-1403.
17.
Holtzer R., Irizarry MC, Sanders J., Hyman BT, Wegesin DJ, Riba A., et al. Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsyproven Alzheimer disease. Arch Neurol. 2006;63(2):226-230.
18.
Schneider JA , Li JL, Li Y., Wilson RS, Kordower JH, Bennett DASubstantia nigra tangles are related to gait impairment in older persons. Ann Neurol. 2006 ;59(1):166-173.
19.
Attems J., Quass M., Jellinger KATau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. Acta Neuropathol. 2007;113(1):53-62.
20.
Mortimer JA , Ebbitt B., Jun SP, Finch MDPredictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology . 1992;42(9):1689-1696.
21.
Stern Y., Albert M., Brandt J., Jacobs DM, Tang MX, Marder K., et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer’s disease: prospective analyses from the Predictors Study . Neurology. 1994;44(12):2300-2307.
22.
Scarmeas N. , Albert M., Brandt J., Blacker D., Hadjigeorgiou G., Papadimitriou A., et al. Motor signs predict poor outcomes in Alzheimer disease. Neurology. 2005;64(10):1696-1703.
23.
Gill TM, Richardson ED, Tinetti MEEvaluating the risk of dependence in activities of daily living among community-living older adults with mild to moderate cognitive impairment. J Gerontol A Biol Sci Med Sci. 1995;50(5):M235-M241.
24.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan EMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939-944.
25.
Folstein MF , Folstein SE, McHugh PR‘‘Mini-mental state’’. A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res. 1975;12(3):189-198.
26.
Tombaugh TN , McIntyre NJThe mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992;40(9):922-935.
27.
Wilson RS, McCann JJ, Li Y., Aggarwal NT, Gilley DW, Evans DANursing home placement, day care use, and cognitive decline in Alzheimer’s disease. Am J Psychiatry. 2007;164(6): 910-915.
28.
Wilson RS, Li Y., Aggarwal NT, Barnes LL, McCann JJ, Gilley DW, et al. Education and the course of cognitive decline in Alzheimer disease . Neurology. 2004;63(7):1198-1202.
29.
Tager IB, Swanson A., Satariano WAReliability of Physical Performance and Self-Reported Functional Measures in an Older Population. J Gerontol Med Sci. 1998;53A(4):M295-M300.
30.
Hoeymans N. , Wouters ER, Feskens EJ, Van Den Bos GA, Kromhout D.Reproducibility of performance-based and self-reported measures of functional status. J Gerontol A Biol Sci Med Sci . 1997;52(6):M363-M368.
31.
Guralnik JM , Simonsick EM, Ferrucci L., Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85-M94.
32.
Guralnik JM , Ferrucci L., Pieper CF, Leveille SG, Markides KS, Ostir GV, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000;55(4):M221-M231.
33.
Guralnik JM , Seeman TE, Tinetti ME, Nevitt MC, Berkman LFValidation and use of performance measures of functioning in a non-disabled older population: MacArthur studies of successful aging. Aging (Milano). 1994;6(6):410-419.
34.
Mendes De Leon CF, Barnes LL, Bienias JL, Skarupski KA, Evans DARacial disparities in disability: recent evidence from self-reported and performance-based disability measures in a population-based study of older adults. J Gerontol B Psychol Sci Soc Sci. 2005;60(5):S263-S271.
35.
Reitan RM, Wolfson D.The Halstead-Reitan Neuropsychological Test Battery: Theory and Interpretation . Tuscon, AZ: Neuropsychology Press ; 1985.
36.
Tiffin J., Asher EJThe Purdue pegboard; norms and studies of reliability and validity. J Appl Psychol. 1948;32(3):234-247.
37.
Branch LG, Katz S., Kniepmann K., Papsidero JAA prospective study of functional status among community elders. Am J Public Health. 1984;74(3):266-268.
38.
World Health Organization.International classification of impairments, disabilities and handicaps. In: A Manual of Classification Relating to the Consequences of Disease . Geneva, Switzerland: World Health Organization; 1980.
39.
Liang KY, Zeger SLLongitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13-22.
40.
Zeger SL, Liang KYLongitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121-130.
41.
SAS Institute Inc.SAS/STAT(r) User’s Guide, Version 8. Cary, NC: SAS Institute Inc, 2000.
42.
Boyle PAAssessing and predicting functional impairment in Alzheimer’s disease: the emerging role of frontal system dysfunction. Curr Psychiatry Rep. 2004;6(1):20-24.
43.
Teri L., Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003;290(15):2015-2022.
